卵巢小细胞神经内分泌癌的研究进展  

Research progress of ovarian small cell neuroendocrine carcinoma

作　　者：魏佳 郭希 刘思敏 王佳丽 郑铎 李红丽 杨永秀[2] WEI Jia;GUO Xi;LIU Simin;WANG Jiali;ZHENG Duo;LI Hongli;YANG Yongxiu(The First Clinical Medical College of Lanzhou University,Gansu Lanzhou 730000,China;Department of Obstetrics and Gynecology,the First Hospital of Lanzhou University,Gansu Provincial Clinical Research Center for Gynecological Oncology,Gansu Lanzhou 730000,China)

机构地区：[1]兰州大学第一临床医学院,甘肃兰州730000 [2]兰州大学第一医院妇产科,甘肃省妇科肿瘤临床研究中心,甘肃兰州730000

出　　处：《现代肿瘤医学》2025年第4期690-694,共5页Journal of Modern Oncology

基　　金：甘肃省青年科技基金(编号:23JRRA1612)。

摘　　要：卵巢小细胞神经内分泌癌是一种罕见的卵巢恶性肿瘤,进展迅速且预后差。第5版WHO女性生殖道肿瘤分类将其归为卵巢神经内分泌肿瘤。目前国内外对其相关研究多为个案报道,尚缺乏对卵巢小细胞神经内分泌癌的充分认识和临床指南。其确切的组织起源及发病机制尚不明确,该文就卵巢小细胞神经内分泌癌的诊断、鉴别诊断、治疗方法及预后等进行综述。Ovarian small cell neuroendocrine carcinoma(SCNEC)is a rare malignant tumor of the ovary that progresses rapidly and has a poor prognosis.The 5th edition of the WHO classification of female reproductive tract tumors classifies it as ovarian neuroendocrine tumors.At present,most of the research on it both domestically and internationally is based on individual case reports,and there is still a lack of sufficient understanding and clinical guidelines for ovarian small cell neuroendocrine carcinoma.The exact tissue origin and pathogenesis of SCNEC are not yet clear.This article reviews the diagnosis,differential diagnosis,treatment methods,and prognosis of SCNEC.

关 键 词：卵巢恶性肿瘤 卵巢小细胞神经内分泌癌 诊断 治疗 

分 类 号：R737.31[医药卫生—肿瘤]